Skip to main content

Animations

MJFF Publications

3011 - 3020 of 6295 Results
Title
Year
  • Year
  • 2024
  • 2019
  • 2022
  • 2022
  • 2024
  • 2025
  • 2021
  • 2023
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Genetic architecture of subcortical brain structures in 38,851 individuals
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-019-0511-y
    Citation Count: 261
  • Summary Details
    OPEN
    Title: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2121609119
    Citation Count: 40
  • Summary Details
    OPEN
    Title: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-04136-8
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progression
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2024.110956
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers Initiative
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385
    Citation Count: 0
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29424
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom Onset
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells13030207
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29288
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.